Citation

87 FR 80190

Multiple canonical documents share this first-page citation.

Prospective Grant of an Exclusive Patent License: Development and Commercialization of Engineered Cell Therapies for the Treatment of Cancer Thursday, December 29, 2022 87 FR 80190
National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting Thursday, December 29, 2022 87 FR 80190